Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
about
Neuropathic Pain due to Small Fiber Neuropathy in Aging: Current Management and Future ProspectsConsiderations on the use of oxymorphone in geriatric patientsPain genesTolerance and withdrawal from prolonged opioid use in critically ill children.Drug-gene interactions: inherent variability in drug maintenance dose requirementsTramadol half life is dose dependent in overdoseInvestigation of CYP2D6 Gene Polymorphisms in Turkish PopulationPharmacogenomics of opioids and perioperative pain management.Efficacy of Tramadol Extended-Release for Opioid Withdrawal: A Randomized Clinical Trial.Pharmacogenomics and Opioid Analgesics: Clinical Implications.Tramadol overdose and apnea in hospitalized children, a review of 20 cases.Tramadol for neuropathic pain in adults.Tramadol with or without paracetamol (acetaminophen) for cancer pain.Serotonin-norepinephrine reuptake inhibitors and the influence of binding affinity (Ki) on analgesia.Review of Opioid Pharmacogenetics and Considerations for Pain Management.PharmGKB summary: tramadol pathway.Tramadol-induced respiratory depression in a morbidly obese patient with normal renal function.Discovery and development of tramadol for the treatment of pain.Polymorphism of human cytochrome P450 2D6 and its clinical significance: part II.Pharmacogenomics of CYP2A6, CYP2B6, CYP2C19, CYP2D6, CYP3A4, CYP3A5 and MDR1 in Vietnam.When the Safe Alternative Is Not That Safe: Tramadol Prescribing in Children.Codeine-related adverse drug reactions in children following tonsillectomy: a prospective study.
P2860
Q26799409-66F933A8-70B0-4AE7-9FEF-56927D56744DQ28252394-108F3601-3B59-473B-97DA-7FF83B2BFA0DQ28473018-2A1292C9-44AE-4048-B827-FD7B01F0DB3DQ30428413-A30DFBEE-1E14-4701-B5C0-33867D32E4AEQ34154939-08BFD237-19E4-4E26-95CF-AFD234D5DB6DQ35143571-50ED295A-6B0C-4C01-8B89-EF5DE7F12CF4Q37299922-0C2C7043-1B82-40E0-8B94-45AA54A1A84AQ38061498-59A43FD8-A668-4A74-AEEA-17F2EC8211E4Q38374123-72A8476E-D6D2-4456-BF1D-D4001FFDEEB5Q38527869-51CB93E0-C8FA-4949-A543-E3EA011A5AABQ38700622-5D8A3425-6A5D-4FBC-A7CC-48CA4B36C05DQ38724793-24EACC13-F0ED-4792-80D9-EF4EBA40BD5BQ38782574-70DF93D4-4B8F-4932-91D6-EC6D1F608858Q38786561-260567E9-9F13-40D7-9920-E4A6553DA767Q39430407-3FCBA118-9966-4F9E-933A-6D84F61838BCQ42737748-CC5311F4-2620-4C3B-9DA1-A838092E6A73Q42836378-2950C2B1-3705-432C-B7B2-E8C291016B52Q43076012-D4003175-517A-4B9E-AF5A-6009EFC69793Q43244977-850692AE-A77E-4E03-8122-DEA9528181B3Q45866401-618D4D66-C352-419F-B67D-C8B1ACEEA019Q52349592-8D9EC600-D4DC-4A09-9474-6815521A998EQ54766895-16EE905D-D959-4A97-8EE8-CCFB78D8C2DD
P2860
Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh
2007年學術文章
@zh-hant
name
Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
@en
Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
@nl
type
label
Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
@en
Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
@nl
prefLabel
Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
@en
Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
@nl
P2093
P2860
P356
P1476
Impact of CYP2D6 genetic polymorphism on tramadol pharmacokinetics and pharmacodynamics.
@en
P2093
Rusli Ismail
Siew Hua Gan
Wan Aasim Wan Adnan
P2860
P2888
P304
P356
10.1007/BF03256239
P577
2007-01-01T00:00:00Z